Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors

Details for Australian Patent Application No. 2007226566 (hide)

Owner Emory University The Washington University

Inventors Tanaka, Kenichi; Gruber, Andras; Di Cera, Enrico; Hanson, Stephen Raymond

Agent Fisher Adams Kelly

Pub. Number AU-A-2007226566

PCT Pub. Number WO2007/106893

Priority 60/782,648 15.03.06 US

Filing date 15 March 2007

Wipo publication date 20 September 2007

International Classifications

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/106893 Priority application(s): WO2007/106893

8 July 2010 Alteration of Name

  The name of the applicant has been altered to Emory University; The Washington University; Oregon Health & Science University

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007226568-Microfracture pick

2007226555-Recombinant Mononegaviral virus vectors